Answer
It is unknown whether somatrogon or its metabolites pass into human breast milk; risk to newborns or infants cannot be excluded, so continuing breast-feeding or somatrogon treatment requires weighing the benefits for the child and woman.
Sources for this answer
- Ngenla 60 mg solution for injection in pre-filled penPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked